USD 28.5
(-1.96%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | - USD | -27.27% |
2023 | 1.05 Million USD | -35.69% |
2022 | 1.64 Million USD | -81.65% |
2021 | 8.94 Million USD | 30.1% |
2020 | 6.87 Million USD | 311.13% |
2019 | 1.67 Million USD | 2.02% |
2018 | 1.63 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q4 | - USD | -100.0% |
2024 FY | - USD | -100.0% |
2024 Q1 | 908 Thousand USD | -14.02% |
2024 Q2 | 820 Thousand USD | -9.69% |
2024 Q3 | 777 Thousand USD | -5.24% |
2023 Q1 | 1.52 Million USD | -88.02% |
2023 Q4 | 1.05 Million USD | -13.3% |
2023 FY | 1.05 Million USD | -35.69% |
2023 Q3 | 1.21 Million USD | -10.64% |
2023 Q2 | 1.36 Million USD | -10.33% |
2022 Q2 | 1.81 Million USD | -4.12% |
2022 Q4 | 12.68 Million USD | 4.36% |
2022 Q3 | 12.15 Million USD | 568.96% |
2022 Q1 | 1.89 Million USD | -78.82% |
2022 FY | 1.64 Million USD | -81.65% |
2021 FY | 8.94 Million USD | 30.1% |
2021 Q1 | 7.22 Million USD | 5.03% |
2021 Q2 | 10.06 Million USD | 39.3% |
2021 Q3 | 8.53 Million USD | -15.2% |
2021 Q4 | 8.94 Million USD | 4.85% |
2020 Q1 | 1.65 Million USD | -1.27% |
2020 FY | 6.87 Million USD | 311.13% |
2020 Q2 | 1.63 Million USD | -1.22% |
2020 Q4 | 6.87 Million USD | -0.59% |
2020 Q3 | 6.91 Million USD | 324.06% |
2019 Q1 | - USD | 0.0% |
2019 Q4 | 1.67 Million USD | 0.0% |
2019 FY | 1.67 Million USD | 2.02% |
2018 FY | 1.63 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Accuray Incorporated | 138.32 Million USD | 100.0% |
Align Technology, Inc. | 296.9 Million USD | 100.0% |
Elevance Health Inc. | -46.33 Billion USD | 100.0% |
AxoGen, Inc. | 23.02 Million USD | 100.0% |
Boston Scientific Corporation | 2.48 Billion USD | 100.0% |
CVS Health Corporation | 18.02 Billion USD | 100.0% |
Cardinal Health, Inc. | 14.95 Billion USD | 100.0% |
Centene Corporation | - USD | NaN% |
DaVita Inc. | 143.1 Million USD | 100.0% |
HCA Healthcare, Inc. | 2.02 Billion USD | 100.0% |
Hologic, Inc. | 679.8 Million USD | 100.0% |
Humana Inc. | - USD | NaN% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 100.0% |
Laboratory Corporation of America Holdings | 474.6 Million USD | 100.0% |
Masimo Corporation | 545 Million USD | 100.0% |
McKesson Corporation | 21.13 Billion USD | 100.0% |
Patterson Companies, Inc. | 782.89 Million USD | 100.0% |
Quest Diagnostics Incorporated | 190 Million USD | 100.0% |
ResMed Inc. | 822.25 Million USD | 100.0% |
Henry Schein, Inc. | 1.81 Billion USD | 100.0% |
Teladoc Health, Inc. | 29.51 Million USD | 100.0% |
Universal Health Services, Inc. | 216.98 Million USD | 100.0% |
Veeva Systems Inc. | - USD | NaN% |
Baxter International Inc. | 2.82 Billion USD | 100.0% |
Becton, Dickinson and Company | 3.27 Billion USD | 100.0% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 100.0% |
Danaher Corporation | 2.59 Billion USD | 100.0% |
Stryker Corporation | 4.84 Billion USD | 100.0% |
Medtronic plc | 5.21 Billion USD | 100.0% |